Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"G129R"”.
-
The role of prolactin and its antagonist in HER2/neu tumorigenesis
… the role of prolactin (PRL) and its antagonist, G129R, in HER2/Neu tumorigenesis. Specifically, to investigate the interaction between the oncogene HER2 and the PRL receptor (PRLR) signaling pathways for designing effective combinational therapeutics for breast cancer. Experimental Design: The …
-
MICA-G129R: A Bifunctional Fusion Protein Bridging Natural Killer Cells and PRLR-positive Breast Cancer Cells
… We created a bifunctional fusion protein MICA-G129R to target the PRLR on breast cancer cells. The G129R is an antagonistic variant of PRL, which binds to PRLR and induces apoptosis of the target cells instead of promotes their growth. MICA (MHC class I chain-related protein) is a …
-
STROMAL-EPITHELIAL INTERACTIONS MODULATE CROSS TALK BETWEEN PROLACTIN RECEPTOR AND HER2/NEU IN BREAST CANCER
… in rodents. A PRL receptor (PRLR) antagonist, G129R, has been demonstrated not only to be able to directly inhibit PRLR activation but also indirectly inhibits the tyrosine phosphorylation of HER2 (p-HER2) in human breast cancer cell lines. However, there is an obvious discrepancy related to …
-
DEVELOPMENT OF NOVEL PROLACTIN AND GROWTH HORMONE RECEPTOR AGONISTS AND ANTAGONISTS
… A prolactin receptor (PRLR) antagonist, hPRL-G129R (G129R), and a PRLR and growth hormone receptor (GHR) antagonist, hGH-G120R (G120R), have been developed which may be useful for the treatment of breast cancer since PRLR is elevated in a majority of human breast tumors and makes cancer cells …
-
EVALUATION OF HUMAN PROLACTIN, ITS ANTAGONIST, AND ANTAGONIST-BASED FUSION PROTEINS AS CHEMOPREVENTATIVE AND THERAPEUTIC AGENTS
… prevention. Transgenic mice expressing hPRL or G129R, under the regulation of the metallothionein (Mt) promoter, were fed a chemical carcinogen, 9,10-Dimethyl-1,2-benzanthracene (DMBA). G129R transgenic mice exhibited decreased growth rate of chemically-induced tumors, while hPRL transgenic mice …
-
Estudo sobre a amígdala medial póstero dorsal de ratos : variação da expressão gênica de receptores para hormônios gonadais e vias de sinalização intracelular em machos e em fêmeas ao longo do ciclo estral e a influência da prolactina no comportamento sexual feminino
… dos receptores para prolactina (Del1-9-G129R-hPRL nas doses de 1 μg/0,3 μL e 10 μg/0,3 μL) e Del1-9-G129R-hPRL (10 μg) juntamente com prolactina (1 nM/0,3 μL) quando as fêmeas estavam em proestro e 3h antes do início do ciclo escuro para teste de comportamento sexual. Comparado com …
-
Understanding Structure and Dynamics of PTEN and its Possible Genotype-Phenotype Correlations in Endometriosis and Cancer
… domain. Interestingly, mutations G36E/R, C124S, G129R, R130L/Q, R173C/H, and V191A dramatically affected the principal motions of the active site loops and inter-domain interface. Overall, the global dynamics induced by each mutation effects reveal unique long-range perturbations that may impair …
-
A structure-function analysis of bovine prolactin
… directly contacting the receptor. The variant G129R had no mitogenic activity, and E128A had reduced bioactivity, suggesting that bPRL contains a second receptor binding site analogous to that described for hGH. Comparison of these results with those reported for related hormones has confirmed …